S. KILIÇKAP Et Al. , "Crizotinib efficacy in ALK positive advanced stage non-small cell lung cancer patients: A real word experience from Turkey," IASLC 19th World Conference on Lung Cancer , Toronto, Canada, pp.477-478, 2018
KILIÇKAP, S. Et Al. 2018. Crizotinib efficacy in ALK positive advanced stage non-small cell lung cancer patients: A real word experience from Turkey. IASLC 19th World Conference on Lung Cancer , (Toronto, Canada), 477-478.
KILIÇKAP, S., ÖZTÜRK, A., KARADURMUŞ, N., KORKMAZ, T., YUMUK, P. F., ÇİÇİN, İ., ... PAYDAŞ, S.(2018). Crizotinib efficacy in ALK positive advanced stage non-small cell lung cancer patients: A real word experience from Turkey . IASLC 19th World Conference on Lung Cancer (pp.477-478). Toronto, Canada
KILIÇKAP, SAADETTİN Et Al. "Crizotinib efficacy in ALK positive advanced stage non-small cell lung cancer patients: A real word experience from Turkey," IASLC 19th World Conference on Lung Cancer, Toronto, Canada, 2018
KILIÇKAP, SAADETTİN Et Al. "Crizotinib efficacy in ALK positive advanced stage non-small cell lung cancer patients: A real word experience from Turkey." IASLC 19th World Conference on Lung Cancer , Toronto, Canada, pp.477-478, 2018
KILIÇKAP, S. Et Al. (2018) . "Crizotinib efficacy in ALK positive advanced stage non-small cell lung cancer patients: A real word experience from Turkey." IASLC 19th World Conference on Lung Cancer , Toronto, Canada, pp.477-478.
@conferencepaper{conferencepaper, author={SAADETTİN KILIÇKAP Et Al. }, title={Crizotinib efficacy in ALK positive advanced stage non-small cell lung cancer patients: A real word experience from Turkey}, congress name={IASLC 19th World Conference on Lung Cancer}, city={Toronto}, country={Canada}, year={2018}, pages={477-478} }